- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Common Signal in Cancer, Stem Cells
2 December 2002 (All day)
KOBE, JAPAN--Embryonic stem cells develop into all the different tissues of the body at the beginning of life; cancer cells often end life. Despite working at cross-purposes, the two types of cells apparently have something in common: a newfound gene involved in regulating their proliferation. "This could show that stem cell biology and oncology interact," says Ronald McKay, a molecular biologist at the National Institute of Neurological Disorders and Stroke (NINDS) in Bethesda, Maryland.
McKay and colleague Robert Tsai, also of NINDS, first found the gene in cultured rat stem cells. The protein built from the gene was abundant while the cells were proliferating but abruptly disappeared when the cells began to differentiate, or turn into other types of cells. The researchers dubbed the new gene nucleostemin, because the protein built by the gene appears to be almost exclusively active within the cell nucleus.
That locus of activity led to "an inspired guess," says McKay. Other proteins active in the cell nucleus regulate the activity of genes that, when mutated, lead to cancer. McKay and Tsai searched human cancer cell lines and found a human version of nucleostemin.
To see what power nucleostemin wields, the researchers looked at its effects in both rat stem cells and human cancer cells. McKay and Tsai turned off production of the gene's protein through a technique known as gene silencing, and in other cases they added extra protein to the cells. Both too little and too much nucleostemin protein hindered cell proliferation. McKay and Tsai conclude that nucleostemin is involved in regulating the proliferation of both stem cells and at least some types of cancer cells, they reported at a meeting here on 20 November and in the December issue of Genes & Development.
Shin-Ichi Nishikawa, a molecular geneticist at Kyoto University, praises the work as being "an important contribution to this field." But he warns against giving too big a role to a single gene. Different types of stem cells, he says, appear to have diverse ways of regulating proliferation and differentiation. And although the link to cancer is intriguing, Nishikawa says, "We really need more data before saying anything conclusive."